Literature DB >> 23123013

Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information.

Peter C Fineran1, Emmanuelle Charpentier.   

Abstract

Multiple organisms face the threat of viral infections. To combat phage invasion, bacteria and archaea have evolved an adaptive mechanism of protection against exogenic mobile genetic elements, called CRISPR-Cas. In this defense strategy, phage infection is memorized via acquisition of a short invader sequence, called a spacer, into the CRISPR locus of the host genome. Upon repeated infection, the 'vaccinated' host expresses the spacer as a precursor RNA, which is processed into a mature CRISPR RNA (crRNA) that guides an endonuclease to the matching invader for its ultimate destruction. Recent efforts have uncovered molecular details underlying the crRNA biogenesis and interference steps. However, until recently the step of adaptation had remained largely uninvestigated. In this minireview, we focus on recent publications that have begun to reveal molecular insights into the adaptive step of CRISPR-Cas immunity, which is required for the development of the heritable memory of the host against viruses.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23123013     DOI: 10.1016/j.virol.2012.10.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  90 in total

Review 1.  CRISPR-Cas adaptation: insights into the mechanism of action.

Authors:  Gil Amitai; Rotem Sorek
Journal:  Nat Rev Microbiol       Date:  2016-01-11       Impact factor: 60.633

2.  Chromosomal targeting by CRISPR-Cas systems can contribute to genome plasticity in bacteria.

Authors:  Ron L Dy; Andrew R Pitman; Peter C Fineran
Journal:  Mob Genet Elements       Date:  2013-10-25

3.  Toroidal structure and DNA cleavage by the CRISPR-associated [4Fe-4S] cluster containing Cas4 nuclease SSO0001 from Sulfolobus solfataricus.

Authors:  Sofia Lemak; Natalia Beloglazova; Boguslaw Nocek; Tatiana Skarina; Robert Flick; Greg Brown; Ana Popovic; Andrzej Joachimiak; Alexei Savchenko; Alexander F Yakunin
Journal:  J Am Chem Soc       Date:  2013-11-11       Impact factor: 15.419

Review 4.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

5.  Breaking-Cas-interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes.

Authors:  Juan C Oliveros; Mònica Franch; Daniel Tabas-Madrid; David San-León; Lluis Montoliu; Pilar Cubas; Florencio Pazos
Journal:  Nucleic Acids Res       Date:  2016-05-10       Impact factor: 16.971

Review 6.  CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.

Authors:  Rodolphe Barrangou; Luciano A Marraffini
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

Review 7.  CRISPR-Cas systems for editing, regulating and targeting genomes.

Authors:  Jeffry D Sander; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-03-02       Impact factor: 54.908

Review 8.  Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.

Authors:  Robert Heler; Luciano A Marraffini; David Bikard
Journal:  Mol Microbiol       Date:  2014-06-04       Impact factor: 3.501

Review 9.  CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.

Authors:  M Sachdeva; N Sachdeva; M Pal; N Gupta; I A Khan; M Majumdar; A Tiwari
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

10.  Two CRISPR-Cas systems in Methanosarcina mazei strain Gö1 display common processing features despite belonging to different types I and III.

Authors:  Lisa Nickel; Katrin Weidenbach; Dominik Jäger; Rolf Backofen; Sita J Lange; Nadja Heidrich; Ruth A Schmitz
Journal:  RNA Biol       Date:  2013-04-25       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.